Dr. F. Scott Hall is an Associate Professor of Pharmacology and Experimental Therapeutics in the College of Pharmacy and Pharmaceutical Sciences at the University of Toledo. His research has focused primarily upon the genetic basis of addiction and the role that early social experience plays in shaping adult behavior and behavioral pathology. After a B.A. from Harvard University (1987) and a Ph.D. from the University of Cambridge (1994), Dr. Hall completed a National Research Council Research Associateship at the National Institute on Alcoholism and Alcohol Abuse. His research at NIAAA focused on animal models of schizophrenia and alcohol use disorder.

Dr. Hall joined the Molecular Neurobiology Branch at the National Institute on Drug Abuse in 1999 where he led a behavioral genetics group in the Molecular Neurobiology Branch until 2014, when he moved to the University of Toledo.  Dr. Hall’s laboratory at the University of Toledo investigates the genetic and environmental determinants of susceptibility to addiction and related psychiatric disorders. His long-standing interest in the underlying mechanisms that lead to the development of psychopathology has contributed to advancement of models used to identify novel potential targets for the treatment of psychiatric disorders. His most current research focusses on the lethal and toxic effects of synthetic cathinones (e.g. “bath salts”). Dr. Hall has authored over 150 scientific publications. He is the immediate Past-President of the International Behavioral Neuroscience Society. His most recent book was Negative Affective States and Cognitive Impairments in Nicotine Dependence (Elsevier, 2016) edited with Jared Young and Andre Der-Avakian.